Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx Partners With Sengenics for Molecular Diagnostics

SAN FRANCISCO, April 9, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), today announced a partnership with Sengenics, a leading genetic diagnostics company, to provide turn-key diagnostic...
April 04, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx and OncoDNA Partner in Molecular Diagnostics

SAN FRANCISCO, April 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and OncoDNA, SA, a Belgium...
March 26, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx Forms Pan Cancer Molecular Oncology Editorial Board

SAN FRANCISCO, March 26, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, today announced the...
March 04, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx(TM) and Projects In Knowledge(R) Partner to Provide Decision Support Tools to Oncologists

SAN FRANCISCO, March 4, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on informing clinical decision making in molecular medicine, and Projects In Knowledge,...
February 19, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx Forms Editorial Board for Prostate Cancer

SAN FRANCISCO, Feb. 19, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the formation of an editorial board for prostate cancer to be led by E. David Crawford, M.D. who will...
February 12, 2013 16:01 ET | Source: CollabRx, Inc.

CollabRx Reports Q3 Fiscal Year 2013 Financial Results

SAN FRANCISCO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) today announced financial results for the Third Quarter Fiscal Year 2013, which ended December 31,...
February 07, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx Releases Second Generation Lung Cancer Clinical Decision Support Tool for Oncologists

SAN FRANCISCO, Feb. 7, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) today announced the release of a new version of its Therapy Finder™application ("app") for lung cancer. The lung...
February 05, 2013 07:01 ET | Source: CollabRx, Inc.

CollabRx Schedules Q3 Fiscal Year 2013 Financial Conference Call and Business Update

SAN FRANCISCO, Feb. 5, 2013 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX), a data analytics company focused on genomics, today announced that it will hold an investor conference call on February...